logo

For the Inventor, By the Inventor

Pittsboro, NC, United States of America

Biolex Therapeutics, Inc.


USPTO Granted Patents = 16

% Expired Patents = 81.3



Forward Citations = 46

Loading Chart...
Loading Chart...

23 inventors (with patents filed for the assignee):

goldMedal Lynn F Dickey (10 out of 13 patents)

silverMedal Kevin Cox (8 out of 11 patents)

bronzeMedal John Gasdaska (6 out of 7 patents)

4.  Charles G Peele (5 out of 7 patents)

5.  Anne Chantal Bechet (3 out of 3 patents)

6.  Riemke Van Dijkhuizen-Radersma (3 out of 3 patents)

7.  Martin Stigter (3 out of 4 patents)

8.  Jeroen Mattijs Bezemer (3 out of 8 patents)

9.  David Spencer (3 out of 3 patents)

10.  Xiaowei Wang (2 out of 2 patents)

11.  Joyce Pritchard (1 out of 16 patents)

12.  Xuan Guo (1 out of 4 patents)

13.  David Gelvin Spencer, Jr (1 out of 1 patent)

14.  John Elliott Humphries (1 out of 1 patent)

15.  Leonardus Gerardus Jozef De Leede (1 out of 1 patent)


16 patents:

1. 8394384 - Recombinant avian influenza vaccine and uses thereof (2013-03-12),
2. 8182803 - C-terminally truncated interferon alpha variants (2012-05-22),
3. 8163307 - Controlled release compositions for interferon based PEGT/PBT block copolymers and method for preparation thereof (2012-04-24),
4. 8137661 - Controlled release interferon drug products and treatment of HCV infections using same (2012-03-20),
5. 8034916 - [object Object] (2011-10-11),
6. 8022270 - Expression of biologically active polypeptides in duckweed (2011-09-20),
7. 8017836 - Expression of plasminogen and microplasminogen in duckweed (2011-09-13),
8. 7959910 - C-terminally truncated interferon alpha variants (2011-06-14),
9. 7915483 - C-terminally truncated interferon (2011-03-29),
10. 7884264 - Compositions and methods for inhibition of fucosyltransferase and xylosyltransferase expression in duckweed plants (2011-02-08),
11. 7867518 - Controlled release compositions for interferon based on PEGT/PBT block copolymers and method for preparation thereof (2011-01-11),
12. 7736674 - Controlled release compositions for interferon based on PEGT/PBT block copolymers (2010-06-15),
13. 7709699 - Use of duckweed in high throughput screening (2010-05-04),
14. 7659445 - Expression of plasminogen and microplasminogen in duck weed (2010-02-09),
15. 7632983 - Expression of monoclonal antibodies in duckweed (2009-12-15),
Company Overview
Biolex Therapeutics, Inc. is a biotechnology company based in Pittsboro, North Carolina, specializing in the development of innovative therapeutics derived from its proprietary LEX System. This platform enables the production of complex proteins and biologics, focusing on treatments for various diseases, including those related to autoimmune disorders and cancer. The company is committed to advancing its research in protein-based therapies, leveraging its unique technology to address unmet medical needs.
Profile summary synthesized from public USPTO records and patent filings.

logo

Company Badge

USPTO Data Jan 1 1976 - Oct 6 2026

16 Patents

#3 in Pittsboro, NC

#443 in North Carolina

#19,907 in US

#37,788 in the World

Pittsboro, NC (US)
Pittsboro, NC, United States of America

Biolex Therapeutics, Inc.

Forward Citations = 46

23 inventors:

goldMedal Lynn F Dickey (10 out of 13 patents)

silverMedal Kevin Cox (8 out of 11 patents)

bronzeMedal John Gasdaska (6 out of 7 patents)

4.  Charles G Peele (5 out of 7 patents)

5.  Anne Chantal Bechet (3 out of 3 patents)

IDiyas Innovation Intelligence. (2026). Company Patent Portfolio: Biolex Therapeutics, Inc.. Retrieved from https://idiyas.com/company/biolex-therapeutics

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…